[Analysis on children timely vaccination coverage and influencing factors of 5 kinds of expanded program for immunization (EPI) vaccine in Dinghai District of Zhoushan Municipal].

Article

Author: Geng, Xiao-dong

OBJECTIVETo understand the timely coverage of 5 kinds of EPI vaccine in Dinghai District, including hepatitis B vaccine (HepB), bacillus calmette guerin vaccine (BCG), oral poliomyelitis attenuated live vaccine (OPV), diphtheria-pertussis-tetanus combined vaccine (DPT), measles attenuated live vaccine (MV), and to analyze the influence factors so as to formulate measures to improve the coverage.METHODSAnalyzing the immunization data and related information of 4258 resident children and 394 floating population born during 2005-2007.RESULTSTimely coverage rate of BCG, HepB, OPV, DPT, MV were 22.26%, 95.020, 90.82%, 91.40%, 95.40% respectively and 48.73%, 74.37%, 76.40%, 80.46%, 84.52%, for floating population. Except for the timely BCG coverage rate was low for resident and floating populations, the timely vaccination rates for other 4 kinds of NIP vaccines in the resident were significantly higher than those in the floating population. The logistic regression analysis showed that inappropriate timing of vaccination, long time waiting for inoculation, lacking of time for the families, long distance from the vaccination sites were four factors that affected the timely immunization of NIP vaccines.CONCLUSIONImplementing the strategy of midwife being responsible for BCG and HepB vaccination can improve the timely coverage of the first dose HepB and BCG: Shorten running inteval of vaccination and available service from the supplier, improve immunization awareness and initiative of the recipients (especially for the floating children's parent/guardian) will be useful to increase the timely NIP vaccine coverage rates.

01 Feb 2010·Zhongguo yi miao he mian yi

[Analysis on epidemiological characteristics of measles before and after measles vaccine supplement immunization activities in Changzhou municipal in 2007].

Article

Author: Zhang, Jian-Tao ; Zhang, Qian ; Bian, Chen

OBJECTIVETo analyze the epidemiological characteristics of measles before and after measles attenuated live vaccine (MV) supplementary immunization activities (SIAs) in Changzhou municipal in 2007-2008 and approach measures of measles elimination.METHODSAnalyze measles epidemiology and control measures with descriptive epidemiology.RESULTSAfter SIAs in Nov.2007, the reported measles incidence was 24.13/100000, and increased by 91.60% in 2008 than in 2007, except Jintan and Liyang town, the others were higher in 2008 than in 2007. The reported measles incidence of 5-9 years old was lower in 2008 than in 2007. However, the reported measles incidence of other age groups was higher. One incidence peak reached 216.92/100000 was found in < 1 year old group and another peak appeared at aged 20-30 years old group. The proportions of measles cases of 8 months-14 years old in 2007 and 2008 were 53.47% and 54.38%. 7.37% and 4.18% of them received MV respectively. The reported cases in 2008 increased and 68.05% of them were floating population.CONCLUSIONSLow coverage of MVwas the main cause of high measles incidence. It indicated that a timely and strengthened routine vaccination, a high quality SIA, and well organized floating population management and surveillance are essential strategies to eliminate measles.

PLOS ONEQ3 · CROSS-FIELD

Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China

Q3 · CROSS-FIELD

ArticleOA

Author: Ye, Dong-Qing ; Sun, Yong ; Tang, Ji-Hai ; Wang, Bin-Bing ; Shen, Yong-Gang ; Wu, Chang-Hao ; Pan, Hai-Feng ; Meng, Fan-Ya

The safety of measles vaccination is of great interest and importance to public health practice and the general society. We have analyzed the adverse events following immunization (AEFIs) of currently used measles-containing vaccines (including live attenuated measles vaccine, live attenuated measles and rubella combined vaccine, live attenuated measles and mumps combined vaccine, live attenuated Measles, Mumps and Rubella Combined Vaccine) in Anhui Province, China. From 2009 to 2014, 9.9 million doses of measles-containing vaccines were administrated and 1893 AEFIs were found (191.4 per million doses), of which, 33 serious AEFIs (3.3 per million vaccine doses) were reported. 59.4% (1124 cases) were male cases, and 85.1% (1611 cases) occurred in persons aged < 1 year. 93.3% (1766 cases) occurred at the first dose of vaccination and 95.9% (1815 cases) were found within 3 days after vaccination. This study presents up-to-date data and suggests that the measles-containing vaccines used in Anhui Province of China are safe.

100 Deals associated with Measles and mumps combined vaccine, live attenuated(Shanghai Institute of Biological Products)

External Link

KEGG	Wiki	ATC	Drug Bank
-	-	J07BD51	-

R&D Status

10 top approved records.

to view more data

Indication	Country/Location	Organization	Date
Measles	CN	Shanghai Institute of Biological Products Co., Ltd.	01 Jan 2000
Mumps	CN	Shanghai Institute of Biological Products Co., Ltd.	01 Jan 2000

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis


No Data

Measles and mumps combined vaccine, live attenuated(Shanghai Institute of Biological Products)

Overview

Basic Info

Related

External Link

R&D Status

Clinical Result

Translational Medicine

Deal

Core Patent

Clinical Trial

Approval

Regulation